BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22973)

  • 1. Association behaviour of human erythrocyte phosphofructokinase: dependence of molecular weight on enzyme concentration at pH 8.0.
    Zimmermann G; Schellenberger W
    Acta Biol Med Ger; 1977; 36(3-4):579. PubMed ID: 22973
    [No Abstract]   [Full Text] [Related]  

  • 2. Association behaviour of human erythrocyte phosphofructokinase. Dependence of molecular weight on enzyme concentration as analyzed by frontal gel chromatography.
    Zimmermann G; Schellenberger W; Wenzel KW; Hofmann E
    Acta Biol Med Ger; 1978; 37(4):527-35. PubMed ID: 153695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the association behaviour of human-erythrocyte phosphofructokinase.
    Zimmermann G; Wenzel KW; Gauer J; Hofmann E
    Eur J Biochem; 1973 Dec; 40(2):501-5. PubMed ID: 4273636
    [No Abstract]   [Full Text] [Related]  

  • 4. [Properties of erythrocyte phosphofructokinase in normal humans].
    Mandereau J; Boivin P
    Biochimie; 1973; 55(11):1341-51. PubMed ID: 4364375
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationships between association state and enzymic activity of human erythrocyte phosphofructokinase.
    Wenzel KW; Müller D; Bär J; Hofmann E
    Acta Biol Med Ger; 1978; 37(4):519-26. PubMed ID: 153694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility behaviour of phosphofructokinase from haemolysate of erythrocytes, reticulocytes and bone marrow cells in poly (ethylene glycol) solutions.
    Tejedor MC; Delgado C; Luque J
    Biochem Int; 1991 Jan; 23(1):59-67. PubMed ID: 1830739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-association of human erythrocyte phosphofructokinase. Kinetic behaviour in dependence on enzyme concentration and mode of association.
    Wenzel KW; Kurganov BI; Zimmermann G; Yakovlev VA; Schellenberger W; Hofmann E
    Eur J Biochem; 1976 Jan; 61(1):181-90. PubMed ID: 128461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Various properties of phosphofructokinase of rat erythrocytes].
    Kühn B; Jacobasch G; Rapoport S
    Acta Biol Med Ger; 1969; 23(1):1-17. PubMed ID: 4244705
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of adrenal steroids on human erythrocyte phosphofructokinase.
    Kwiatkowska D; Szechiński J
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):445-50. PubMed ID: 2948478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in allosteric properties of phosphofructokinase bound to erythrocyte membranes.
    Karadsheh NS; Uyeda K
    J Biol Chem; 1977 Nov; 252(21):7418-20. PubMed ID: 144126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte phosphofructokinase alterations in polycythemia vera.
    Kwiatkowska J; Zatoński W; Baranowski T
    Clin Chim Acta; 1972 Aug; 40(1):101-6. PubMed ID: 4262513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetic properties of phosphofructokinase in red blood cells].
    Kühn B; Jacobasch G; Rapoport S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(4):436-41. PubMed ID: 4176841
    [No Abstract]   [Full Text] [Related]  

  • 13. Indications of pH-induced conformational changes in phosphofructokinase from baker's yeast.
    Johansson G; Kopperschläger G
    Acta Biol Med Ger; 1979; 38(11-12):1639-41. PubMed ID: 45164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of erythrocyte phosphofructokinase in children with acute lymphoblastic leukemia. Acute stage and remission.
    Kwiatkowska J; Bogusławska-Jaworska J
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):339-44. PubMed ID: 38766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on structure of human erythrocyte phosphofructokinase.
    Karadsheh NS; Uyeda K; Oliver RM
    J Biol Chem; 1977 May; 252(10):3515-24. PubMed ID: 140873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Simulation of the kinetics of oligomeric enzymes as illustrated by phosphofructokinase. I. General analysis of experimental data and the choice of an adequate model].
    Cherepanov DA; Rapanovich II
    Mol Biol (Mosk); 1987; 21(3):820-30. PubMed ID: 2958689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in erythrocyte enzymes in cancer.
    Kwiatkowska D; Dawiskiba J; Kwiatkowska J
    Neoplasma; 1980; 27(4):415-22. PubMed ID: 6450330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic effect of cAMP and cGMP on the kinetic behaviour of phosphofructokinase from rat erythrocytes and reticulocytes.
    Pinilla M; Luque J
    Acta Biol Med Ger; 1981; 40(4-5):707-10. PubMed ID: 6274116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cortisol on erythrocyte and reticulocyte enzymes: modulation of phosphofructokinase properties.
    Kwiatkowska D; Szajerka G; Kwiatkowska J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):381-7. PubMed ID: 6228205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphofructokinase from human erythrocytes.
    Layzer RB
    Methods Enzymol; 1975; 42():110-5. PubMed ID: 124385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.